1. Home
  2. OGN vs SFNC Comparison

OGN vs SFNC Comparison

Compare OGN & SFNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • SFNC
  • Stock Information
  • Founded
  • OGN 1923
  • SFNC 1903
  • Country
  • OGN United States
  • SFNC United States
  • Employees
  • OGN N/A
  • SFNC N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • SFNC Major Banks
  • Sector
  • OGN Health Care
  • SFNC Finance
  • Exchange
  • OGN Nasdaq
  • SFNC Nasdaq
  • Market Cap
  • OGN 2.5B
  • SFNC 2.2B
  • IPO Year
  • OGN N/A
  • SFNC N/A
  • Fundamental
  • Price
  • OGN $9.82
  • SFNC $20.09
  • Analyst Decision
  • OGN Hold
  • SFNC Hold
  • Analyst Count
  • OGN 4
  • SFNC 3
  • Target Price
  • OGN $18.00
  • SFNC $22.00
  • AVG Volume (30 Days)
  • OGN 3.5M
  • SFNC 746.5K
  • Earning Date
  • OGN 08-05-2025
  • SFNC 07-17-2025
  • Dividend Yield
  • OGN 0.81%
  • SFNC 4.21%
  • EPS Growth
  • OGN N/A
  • SFNC N/A
  • EPS
  • OGN 2.88
  • SFNC 1.16
  • Revenue
  • OGN $6,294,000,000.00
  • SFNC $726,747,000.00
  • Revenue This Year
  • OGN N/A
  • SFNC $22.95
  • Revenue Next Year
  • OGN $1.11
  • SFNC $6.32
  • P/E Ratio
  • OGN $3.42
  • SFNC $17.39
  • Revenue Growth
  • OGN N/A
  • SFNC N/A
  • 52 Week Low
  • OGN $8.01
  • SFNC $17.20
  • 52 Week High
  • OGN $23.10
  • SFNC $25.95
  • Technical
  • Relative Strength Index (RSI)
  • OGN 48.62
  • SFNC 59.13
  • Support Level
  • OGN $9.74
  • SFNC $19.82
  • Resistance Level
  • OGN $10.27
  • SFNC $20.31
  • Average True Range (ATR)
  • OGN 0.36
  • SFNC 0.42
  • MACD
  • OGN -0.00
  • SFNC 0.09
  • Stochastic Oscillator
  • OGN 29.78
  • SFNC 67.93

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

Share on Social Networks: